Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Pembrolizumab
Ependymoma
National Cancer Institute (NCI)P1CC (43)
Pidnarulex
Breast Cancer
National Cancer Institute (NCI)P1CC (43)
Pidnarulex
Invasive Breast Carcinoma
National Cancer Institute (NCI)P1CC (43)
Pidnarulex
Breast Carcinoma
National Cancer Institute (NCI)P1CC (43)
Pidnarulex
HER2 Positive Breast Carcinoma
National Cancer Institute (NCI)P1CC (43)
Pidnarulex
Hormone Receptor-Positive Breast Cancer
National Cancer Institute (NCI)P1CC (43)
Pidnarulex
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)P1CC (43)
Pidnarulex
Triple-Negative Breast Carcinoma
National Cancer Institute (NCI)P1CC (43)
Pomalidomide
B-Cell Neoplasm
National Cancer Institute (NCI)P1CC (43)
Pomalidomide
Lymphoma
National Cancer Institute (NCI)P1CC (43)
Pomalidomide
Kaposi'S Sarcoma
National Cancer Institute (NCI)P1CC (43)
Pomalidomide
Plasmablastic Lymphoma
National Cancer Institute (NCI)P1CC (43)
Pomalidomide
Virus Associated Tumor
National Cancer Institute (NCI)P1CC (43)
Prednisone
Human T-Lymphotropic Virus 1 Infectious Disease
National Cancer Institute (NCI)P1CC (43)
Prednisone
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)P1CC (43)
Riluzole
Melanoma
National Cancer Institute (NCI)P1CC (43)
Riluzole
Refractory Malignant Neoplasm
National Cancer Institute (NCI)P1CC (43)
Rituximab
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)P1CC (43)
Rocakinogene Sifuplasmid
Hepatitis
National Cancer Institute (NCI)P1CC (43)
Rocakinogene Sifuplasmid
Hepatitis C Virus Infection
National Cancer Institute (NCI)P1CC (43)
Romidepsin
Adult T-Cell Leukemia/Lymphoma
National Cancer Institute (NCI)P1CC (43)
Romidepsin
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma
National Cancer Institute (NCI)P1CC (43)
Sapanisertib
Adult Glioblastoma
National Cancer Institute (NCI)P1CC (43)
Sapanisertib
Endometrial Clear Cell Adenocarcinoma
National Cancer Institute (NCI)P1CC (43)
Sapanisertib
Endometrial Serous Adenocarcinoma
National Cancer Institute (NCI)P1CC (43)
Showing 2951 to 2975 of 3,272 assets
PreviousPage 119 of 131Next